This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!
Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

NIH NLM Logo
Log in
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Apr;54(2):201-4.
doi: 10.3347/kjp.2016542.201. Epub 2016 Apr 30.

High Toxoplasma gondii Seropositivity among Brain Tumor Patients in Korea

Affiliations

High Toxoplasma gondii Seropositivity among Brain Tumor Patients in Korea

Bong-Kwang Jung et al. Korean J Parasitol. 2016 Apr.

Abstract

Toxoplasma gondii is an intracellular protozoan that can modulate the environment of the infected host. An unfavorable environment modulated by T. gondii in the brain includes tumor microenvironment. Literature has suggested that T. gondii infection is associated with development of brain tumors. However, in Korea, epidemiological data regarding this correlation have been scarce. In this study, in order to investigate the relationship between T. gondii infection and brain tumor development, we investigated the seroprevalence of T. gondii among 93 confirmed brain tumor patients (various histological types, including meningioma and astrocytoma) in Korea using ELISA. The results revealed that T. gondii seropositivity among brain tumor patients (18.3%) was significantly (P<0.05) higher compared with that of healthy controls (8.6%). The seropositivity of brain tumor patients showed a significant age-tendency, i.e., higher in younger age group, compared with age-matched healthy controls (P<0.05). In conclusion, this study supports the close relationship between T. gondii infection and incidence of brain tumors.

Keywords: ELISA; Toxoplasma gondii; brain tumor; seroprevalence.

PubMed Disclaimer

Conflict of interest statement

We have no conflict of interest related to this work.

Figures

Fig. 1.
Fig. 1.
Gender (A) and age (B)-associated seroprevalence of T. gondii infection among brain tumor patients in Korea compared with healthy controls.

References

    1. Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin D, Forman D, Bray F. GLOBOCAN 2012 v1.0, cancer incidence and mortality worldwide: IARC cancer base no. 11 [Internet] International Agency for Research on Cancer 2012, Lyon, France, 2013. http://globocan.iarc.fr.
    1. Fisher JL, Scharwtzbaum JA, Wrensch M, Wiemels JL. Epidemiology of brain tumors. Neurol Clin. 2007;25:867–890. - PubMed
    1. Pagano JS, Blaser M, Buendia MA, Damania B, Khalili K, Raab-Traub N, Roizman B. Infectious agents and cancer: criteria for a causal relation. Semin Cancer Biol. 2004;14:453–471. - PubMed
    1. Bouvard V, Baan R, Straif K, Grosse Y, Secretan B, El Ghissassi F, Benbrahim-Tallaa L, Guha N, Freeman C, Galichet L, Cogliano V, WHO International Agency for Research on Cancer Monograph Working Group A review of human carcinogens. Part B: biological agents. Lancet Oncol. 2009;10:321–322. - PubMed
    1. Alibek K, Kakpenova A, Baiken Y. Role of infectious agents in the carcinogenesis of brain and head and neck cancers. Infect Agent Cancer. 2013;8:7. - PMC - PubMed

MeSH terms

LinkOut - more resources

Cite

AltStyle によって変換されたページ (->オリジナル) /